Douglass Brian Robb
SEC CIK 2104618 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Chief PRODUCT Off | 7,985 | — | — | 3 | 2025-12-31 | 2026-05-07 |
Most active insiders at RGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hunt Anthony | Dir | — | $7.01M |
| 2 | Loeillot Olivier | CEO, Dir | — | $4.19M |
| 3 | Bylund James | COO | — | $331.3K |
| 4 | Garland Jason K | CFO | — | $185.8K |
| 5 | DAWES KAREN A | Dir | — | $44.3K |
| 6 | Douglass Brian Robb | Chief PRODUCT Off | — | — |
| 7 | Pax Margaret | Dir | — | — |
| 8 | Hughes Violetta | CAO | — | — |
| 9 | Mhatre Rohin | Dir | — | — |
| 10 | Konstantinov Konstantin | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 14:39 | 2026-05-07 | RGEN | REPLIGEN CORP | Douglass Brian Robb | Chief PRODUCT Off | F - Tax | $126.43 | -334 | 7,985 | -4% | -$42.2K | |
| 2026-03-03 | 2026-03-02 | RGEN | REPLIGEN CORP | Douglass Brian Robb | Chief PRODUCT Off | F - Tax | $124.97 | -221 | 8,319 | -3% | -$27.6K | |
| D | 2026-01-12 | 2025-12-31 | RGEN | REPLIGEN CORP | Douglass Brian Robb | Chief PRODUCT Off | A - Grant | $0.00 | +2,288 | 8,540 | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations